U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Public Meeting on Patient-Focused Drug Development for Systemic Sclerosis - 10/13/2020
  1. News & Events for Human Drugs

Virtual | Virtual

Event Title
Public Meeting on Patient-Focused Drug Development for Systemic Sclerosis
October 13, 2020

Date:
October 13, 2020

On October 13th, 2020, FDA hosted a virtual public meeting on Patient-Focused Drug Development for Systemic Sclerosis. FDA was interested in hearing patients’ perspectives on the impact of systemic sclerosis on daily life and patient views on treatment approaches.

Location:

VIRTUAL EVENT

Meeting Materials

Public Docket:

In addition to providing input at the public meeting, stakeholders are invited to provide their perspectives on the discussion questions through the public docket. 

  • The docket closes on December 15, 2020. FDA is interested in responses to the questions listed in the public docket.

Related Information

Back to Top